AKT1 and lung carcinoma: In a xenograft model mimicking EPO treatment in lung cancer patients, knockdown of EPOR impaired tumor growth, cellular respiration, mitochondrial content, and iNOS expression and AKT phosphorylation of lung cancer xenografts.